The successful development of glucagon-like peptide-1 (GLP-1) receptor agonists, followed by the synergistic combined effect of glucose-dependent insulinotropic polypeptide (GIP)/GLP-1 receptor agonists achieved remarkable weight loss and glycemic control in those with the diseases of obesity and type 2 diabetes
If you are considering using semaglutide for weight loss, it is important to know that it is a very safe and effective drug
New England Journal of Medicine, 384, 989-1002
Truncated glucagon-like peptide I, an insulin-releasing hormone from the distal gut
Thyroid conditions FDA-approved GLP-1 medications carry a boxed warning based on thyroid C-cell tumors that researchers observed in rodent studies
GLP-1 agonists, a novel class of anti-diabetic drugs, are an integral part of the management of patients with type 2 diabetes (7476)